The ASAM Treatment of Opioid Use Disorder Course

4.96 (24 votes)

  • Register
    • Non-Member - Free!
    • Regular Member - Free!
    • Retired - Free!
    • Early Career Physician - Free!
    • Resident - Free!
    • Student - Free!
    • Associate - Free!
    • ASAM Staff - Free!
    • International Member - Free!
    • Emeritus Member - Free!
    • Provisional Member - Free!
    • Fellow Member - Free!
    • Honorary Member - Free!
    • CRT Member - Free!

image

The ASAM Treatment of Opioid Use Disorder Course


NEW 8-Hour Online Course for Physicians*

The ASAM Treatment of Opioid Use Disorder Course provides eight hours of required education to qualify for the waiver to prescribe buprenorphine in an office-based setting and covers essential information for providers to identify, assess, diagnose, and manage patients with opioid use disorder (OUD). The course covers the latest information on medications and treatments for OUD. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.

This course is fully online and can be completed at your own pace. The flow of this online course uses a mix of didactic materials, case studies, learning activities, and assessments.

Begin the course by reviewing the Getting Started page that contains information about the structure and sequence of the course. From there, you can review the course introduction, faculty information, content modules, and different sections of the course to get acquainted with course navigation.

*NPs, PAs, CNMs, CRNAs, and other CNSs are required to complete no less than 24 hours of training. ASAM offers 24 hour packages for free. Click here for more information.

Note: Resident & Fellow ASAM Members (in training) receive complimentary access to The ASAM Treatment of Opioid Use Disorder Course. Click here to become a member. Please note membership approval requires up to two business days.


Quick Links 


Target Audience

  • Physicians who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorders.
  • Clinicians and healthcare team members working with providers who prescribe buprenorphine in office-based treatment of opioid use disorders.

Getting Started


Structure of the Course

It's important to familiarize yourself with the overall structure and elements of the environment in which you will be learning. This online course is fully online and self-paced. The course content, learning activities, and assessments in the course should be completed asynchronously—you will log into the course site and complete them at your own pace. The course will take approximately 8 hours to complete.

All content modules are available under the Course Content tab in the course navigation.

Module Structure

image

Overview

This section serves as an introduction to the module.

 
 
image

Learning Objectives

The learning objectives for the module are listed here.

 
 
image

Module Introduction

The introduction provides an overview of the upcoming content.

 
 
image

Module Content

This section contains content and learning materials you need to read or view.

 
 
image

Practice/Reflection Exercise

This section contains practice exercises to help you work toward mastery of the concepts.

 
 
image

Assessment

Each module contains a short assessment to test your mastery of the learning objectives.

Course Introduction


image

The ASAM Treatment of Opioid Use Disorder Course 8-Hour Online

The ASAM Treatment of Opioid Use Disorder Course provides the required education essential for providers to identify, assess, diagnose, and manage patients with opioid use disorder (OUD). The course covers all medications and treatments for OUD. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 


image

Learning Objectives

Upon completion, you will be able to:

  • Identify, assess, and diagnose patients with opioid use disorder while considering severity, chronicity, individual characteristics, and psychiatric and medical comorbidities.
  • Develop an individualized, patient-centered treatment plan, including negotiating treatment goals by evaluating appropriate medication- and psychosocial-based treatment options.
  • Monitor progress and modify treatment plans based on patient needs and progress toward treatment goals.
  • Implement best practices for office systems, including team-based care, to support treatment with medications for opioid use disorder.
  • Examine misconceptions, stigma, and complexities (bioethical, social, clinical, public health) associated with opioid use disorder and the use of medications to treat opioid use disorder.

Faculty


image

Daniel P. Alford, MD, MPH, FACP, DFASAM

image

Dr. Daniel Alford is a Professor of Medicine and Associate Dean of Continuing Medical Education at Boston University School of Medicine (BUSM). He is on staff in the Section of General Internal Medicine and Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center. He is the Medical Director of the CDC-funded Boston Sustainable Models for unhealthy Alcohol use ReducTion (B SMART) and the HRSA funded SBIRT And FASD Education, Support and Treatment (SAFEST) Choice programs. 

Dr. Daniel Alford has no relevant financial disclosures.


image

Debra Newman, PA-C, MPAS, MPH

image

Debra Newman currently serves as a treatment provider for First Judicial District Court, Adult Drug Court for Santa Fe and Rio Arriba Counties, New Mexico. She is also working part-time as a contract provider in Chemical Dependency for Kaiser Permanente in Denver, Colorado. Debra has worked in residential treatment as well as out-patient adult psychiatry and addiction medicine. She is currently working with the PA Foundation and NIDA on a grant examining the role of PAs in drug courts. 

Debra Newman has no relevant financial disclosures.


image

Yngvild K. Olsen, MD, MPH, DFASAM

image

Dr. Yngvild Olsen graduated from Harvard Medical School in 1997, from the residency training program in internal medicine at Boston Medical Center in 2000, and from the Fellowship in General Internal Medicine at the Johns Hopkins School of Medicine in 2001. Dr. Olsen also serves as the Medical Director of the Institutes for Behavior Resources Inc/REACH Health Services in Baltimore City. Dr. Olsen currently serves as Vice President of the American Society of Addiction Medicine and is a member of the Public Policy Committee. She is the Immediate Past President of the Maryland Society of Addiction Medicine, Immediate Past President of the Maryland Association for the Treatment of Opioid Dependence, and a Board member of the National Council on Alcoholism and Drug Dependence-MD (NCADD-MD). 

Yngvild K. Olsen has no relevant financial disclosures.


image

Edwin Salsitz, MD, DFASAM

image

Dr. Edwin Salsitz has been an attending physician at Mt. Sinai Beth Israel, Division of Chemical Dependency, in New York City since 1983, and is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM) and the Board of Internal Medicine and Pulmonary Disease. 

Dr. Edwin Salsitz has no relevant financial disclosures.


image

Kristin E. Smith, DNP, FNP-C

image

Kristin Smith graduated from St. John Fisher’s FNP/DNP program in May 2013. She is a staff clinician and the Program Director of a Nurse Practitioner (NP) Residency Program at Highland Family Medicine, where she provides Medication Assisted Treatment (MATx) in both dedicated suboxone clinics as well as integrated primary care settings. Dr. Smith is also a certified American Academy of HIV Medicine Specialist with experience providing HIV care and Pre/Post-Exposure prophylaxis. Prior to transitioning to her current role, she served as the Clinical Director of an Opioid Overdose Prevention Program, where she became passionate about harm reduction while providing community training on Naloxone, teaching safe injection practices, and providing needle exchange services in collaboration with a team of individuals through Trillium Health.

Kristin Smith has no relevant financial disclosures.


image

Bernard Stuetz PA-C, MA

image

Bernard Stuetz is the Past President of the Society of Physician Assistants in Addiction Medicine and currently acting as Chief Delegate to the American Academy of PAs (AAPA) House of Delegates (HOD). He is also the Director for Federal Affairs. He has been a delegate to the AAPA HOD for 31 years. He was a member of the AAPA Recertification Committee in 2012, during which he recommended changes to the ten-year cycle requirements. As a delegate in the AAPA HOD, he was the lead advocate to change the re-certification cycle from six to ten years. He was the first PA to work in the White House on Health Care Policy from 1993 to 1995. Having practiced Addiction Medicine for 25 years, Mr. Stuetz currently works in an OTP and Buprenorphine practice.

Bernard Stuetz has no relevant financial disclosures.


image

Matt Tierney, APRN

image

Matt Tierney is a Nurse Practitioner and a Clinical Professor at the UCSF School of Nursing. He also serves as Clinical Director of Substance Use Treatment and Education for the Office of Population Health at UCSF Health. The focus of his career has been on improving essential addiction treatment delivery locally, regionally, and nationally. He is a Fellow of the American Academy of Nursing, where he serves on the Expert Panel on Psychiatric-Mental Health and Substance Use. Matt is also President-Elect of the American Psychiatric Nurses Association and represents APNA as a sponsoring member of the National Academies of Science Engineering and Medicine's Forum of Mental Health and Substance Use Disorders. He is an ASAM member who has been teaching waiver training courses since 2008. He has treated over 1,600 patients with buprenorphine and has worked in licensed Opiate Treatment programs providing all three FDA-approved medications for OUD treatment.

Matt Tierney has no relevant financial disclosures.


image

Deanna Wilson, MD, MPH

image

Dr. Deanna Wilson is an Assistant Professor of Medicine and Pediatrics at the University of Pittsburgh School of Medicine. She received her MD from Yale University School of Medicine and trained in internal medicine and pediatrics at the Johns Hopkins University School of Medicine. She also completed additional subspecialty training in both adolescent and addiction medicine at Johns Hopkins.

Dr. Deanna Wilson has no relevant financial disclosures.


Key:

Complete
Failed
Available
Locked
Course Overview
View Course Overview
Begin self-paced component package.
Begin self-paced component package. Click to open the course.
Module 1: Identifying, Assessing, and Diagnosing Patients with Opioid Use Disorder
Complete Module 1
Begin self-paced component package.
Begin self-paced component package. Click to open Module 1.
Module 2: Determining Treatment Plan for Patients with Opioid Use Disorder
Complete Module 2
Begin self-paced component package.
Begin self-paced component package. Click to open Module 2.
Module 3: Implementing Office-Based Opioid Treatment
Complete Module 3
Begin self-paced component package.
Begin self-paced component package. Click to open Module 3.
Module 4: Special Populations
Complete Module 4
Begin self-paced component package.
Begin self-paced component package. Click to open Module 4.
Module 5: Keeping Your Patient Safe
Complete Module 5
Begin self-paced component package.
Begin self-paced component package. Click to open Module 5.
Evaluation and Certificate
Complete CME Evaluation
16 Questions
16 Questions Fill out the evaluation to claim credit and download certificate.
Download CME Certificate
Up to 8.00 medical credits available  |  Certificate available
Up to 8.00 medical credits available  |  Certificate available Access your certificate here. Use this certificate to apply for the waiver.
Open Waiver Application
Select the "Go To Application Site" button to begin.
Select the "Go To Application Site" button to begin. Click to open the waiver application on SAMHSA's website. You must upload a copy of your CME certificate to submit your application.

How to Claim Credits


To claim continuing education (CE) and/or continuing medical education (CME) credit, follow the steps below.

STEP 1

Complete all the content modules in the course located under "Course Content." Each module contains instructional materials, interactive exercises, and knowledge checks.

STEP 2

Complete the post-course evaluation. Fill out the survey by clicking the blue "Fill out Survey" button. Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window. Submit the evaluation (the next box should activate, and the evaluation box should turn green with a white check mark).

STEP 3

Click the button “Claim Credits” in the box titled "Download Course Certificate." Choose the type of credit (Physician or Non-physician) and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).

Credits and Disclosures


Date of Release: January 2021 

Approved Through: January 2024

ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Family Physicians (AAFP)

The AAFP has reviewed The ASAM Treatment of Opioid Use Disorder Course and deemed it acceptable for up to 8.00 Enduring Materials, Self-Study AAFP Prescribed credit. Term of Approval is from 12/01/2020 to 12/01/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity

AMA / AAFP Equivalency

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

NAADAC, the Association for Addiction Professionals

This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification


American Board of Preventive Medicine (ABPM)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credits towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA)

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

American Board of Surgery (ABS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

American Board of Psychiatry and Neurology (ABPN)

Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

American Board of Addiction Medicine (ABAM)

Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

CME Reviewer and Disclosure Information


ASAM CME Committee Reviewer

Benjamin Bearnot, MD - Does Disclose

• We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board 

• Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board

Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Faculty and Planning Committee


Faculty Disclosure Information

Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures 
Mount Sinai Beth Israel, New York, NY

Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures 
First Judicial District Court, Santa Fe, NM

Matt Tierney, APRN - No Relevant Financial Disclosures 
University of California - San Francisco, San Francisco, CA

Yngvild Olsen, MD, MPH, DFASAM – No Relevant Financial Disclosures 
Institute for Behavior Resources, Inc., Baltimore, MD


Planning Committee Disclosure Information

Melissa Weimer, DO, MCR, FASAM, Chair – Does Disclose

  • Path CCM, Inc, Consultant/Advisory Board, Clinical Condition: SUD, Consultant/Advisory Board

Deanna Wilson, MD, MPH, Vice Chair – No Relevant Financial Disclosures
Pittsburgh, PA

Alta DeRoo, MD, FASAM – Does Disclose

  • Indivior, Speaker honorarium
  • Alkermes, Speaker honorarium

Soraya Azari, MD – No Relevant Financial Disclosures
San Francisco, CA

Kristin Smith, DNP, FNP-C, AAHIVS – No Relevant Financial Disclosures
Atlanta, GA

Matt Tierney, NP, CNS – No Relevant Financial Disclosures
San Francisco, CA

Debra Newman, PA-C, MPAS, MPH – No Relevant Financial Disclosures
Santa Fe, NM

Edwin A. Salsitz, MD, DFASAM – No Relevant Financial Disclosures
New York, NY